White House signs H.R. 7148 into law, tightening rules on PBMs distorting New York drug prices

Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
0Comments

The White House announced that congressional bill H.R. 7148 has been signed into law, which includes reforms targeting pharmacy benefit manager (PBM) practices by shifting compensation away from rebate-linked incentives and expanding transparency requirements, an issue gaining attention in New York. 

According to AJMC, the spending law introduces Medicare Part D PBM reforms designed to reduce incentives tied to higher list prices. The policy “delinks” PBM compensation from rebates and list prices by moving PBMs toward flat administrative fees, a change supporters say can weaken “rebate maximization” and steer plans away from higher-priced drugs that generate bigger rebates.

Under the new provisions described in coverage of the law, PBMs would be required to pass through 100% of rebates, fees, and other remuneration to the payer, with Centers for Medicare & Medicaid Services (CMS) monetary penalties available for noncompliance. The goal, as reported by AJMC, is to ensure rebate dollars do not remain with middlemen and to improve accountability for how savings are handled.

PBMs sit between insurers/payers, drug manufacturers, and pharmacies—negotiating rebates and building formularies and pharmacy networks that shape what patients pay and where they can fill prescriptions. Federal scrutiny has intensified: the FTC’s interim staff report on “prescription drug middlemen” argues PBM concentration and vertical integration can disadvantage patients and independent pharmacies without sufficient transparency.

New York’s Department of Financial Services proposed PBM market-conduct rules specifically to “prohibit business practices that increase the cost” of prescription drugs and to help ensure independent pharmacies can compete fairly with PBM-affiliated pharmacies—an explicit acknowledgment that PBM conflicts and tactics can raise costs and threaten local pharmacy access.

The White House serves as the executive branch office supporting the President and communicates official administration actions through its public “Briefings & Statements” releases. These postings serve as the government’s on-the-record record for presidential actions and policy announcements, archived for public access on WhiteHouse.gov.



Related

Jay Clayton, U.S. Attorney for the Southern District of New York

Rockland County man pleads guilty to defrauding investors in investment scheme

Solomon Lichtenstein has pleaded guilty to securities fraud after defrauding investors out of millions through false claims about his investment strategies. Authorities say he used much of the money for personal expenses rather than investing it as promised.

Jay Clayton, U.S. Attorney for the Southern District of New York

Florida man sentenced to 73 months for mass-mailing scam targeting small businesses

A Florida man has been sentenced to over six years in prison for running a mass-mailing scam that targeted small businesses nationwide with fake invoices for web hosting services. Prosecutors say Robert W. Lederhilger III collected millions through this scheme over seven years.

John A. Sarcone III, U.S. Attorney for the Northern District of New York

New York City man sentenced to 78 months for trafficking ecstasy through mail

A New York City man has been sentenced to over six years in prison for trafficking ecstasy through the mail as part of an international drug operation. Authorities seized more than 10 kilograms of MDMA intended for distribution in New York City.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Empire State Today.